Le Lézard
Classified in: Business
Subject: PDT

Introducing Matterhorn Venture Partners: Chicago-based boutique Real Estate Investment Firm Specializing in Diverse Commercial Transactions


CHICAGO, April 23, 2024 /PRNewswire/ -- Matterhorn Venture Partners, a Chicago-based boutique real estate investment firm, is pleased to announce its official launch. Founded by industry veterans Scott McKibben and Matt Kay, the firm specializes in a diverse range of commercial real estate asset classes and transaction sizes.  Matterhorn will utilize its vast network of broker and owner relationships to source deals. 

Matterhorn Venture Partners focuses on sourcing distinct value-add and development real estate deals across all asset classes, including the industrial, retail, office, and multi-family sectors. This approach offers clients unique investment opportunities tailored to their specific needs and business objectives.

The team of seasoned professionals at Matterhorn Venture Partners is committed to identifying and securing high-quality investment opportunities that maximize returns and create long-term value for clients.  Matterhorn utilizes state-of-the-art smart technologies, including artificial intelligence, to identify deal opportunities that put them at the forefront of the competition.

Matterhorn Venture Partners is thrilled to embark on this exciting journey and looks forward to building lasting relationships with clients by delivering exceptional value and personalized services.

For more information about Matterhorn Venture Partners and its services, please visit: Website:  www.matterhornvp.com
LinkedIn:  www.linkedin.com/company/matterhorn-venture-partners 
Contact:  [email protected]

Contact Information:
Scott McKibben 
Chief Executive Officer
Email: [email protected]   
Phone: 312-865-2000

Matt Kay 
Chief Investment Officer
Email: [email protected]   
Phone: 313-820-3998

SOURCE Matterhorn Venture Partners LLC


These press releases may also interest you

at 16:05
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 financial guidance. "Vertex delivered a strong start to 2024 with 13 percent product...

at 16:05
Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today reported financial results for its fiscal second quarter ended March 31, 2024. "At...

at 16:05
FIS® , a global leader in financial technology, today reported its first quarter 2024 results. "We are off to a very strong start in 2024. This marks the fifth straight quarter of exceeding our financial outlook, and we are pleased with the...

at 16:05
Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal third quarter ended March 30, 2024. "Lumentum is well-positioned to capitalize on surging cloud data center demand driven by the exponentially increasing...

at 16:05
CVD Equipment Corporation , a leading provider of chemical vapor deposition and thermal process equipment, today announced that it will release its financial results for the first quarter ended March 31, 2024 after the market closes on Monday, May...

at 16:05
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the quarter...



News published on and distributed by: